I agree that this site is using cookies. You can find further informations here.
X
Ocio, Enrique M.
~ 400  results:
Search for persons X
?
1

Comparative Efficacy of Talquetamab vs. Current Treatments ..:

Einsele, Hermann ; Moreau, Philippe ; Bahlis, Nizar...
Advances in Therapy.  41 (2024)  4 - p. 1576-1593 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibi..:

Díaz-Tejedor, Andrea ; Rodríguez-Ubreva, Javier ; Ciudad, Laura...
International Journal of Molecular Sciences.  25 (2024)  9 - p. 4718 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Preclinical discovery and initial clinical data of WVT078, ..:

Raab, Marc S. ; Cohen, Yael C. ; Schjesvold, Fredrik...
Leukemia.  , 2023
Link: https://doi.org/10.1038/..
 
?
4

Efficacy and safety of isatuximab plus bortezomib, lenalido..:

Ocio, Enrique M. ; Perrot, Aurore ; Bories, Pierre...
Leukemia.  37 (2023)  7 - p. 1521-1529 , 2023
Link: https://doi.org/10.1038/..
 
?
5

Phase 1b Study of Isatuximab in Combination With Bortezomib..:

Ocio, Enrique M. ; Bringhen, Sara ; Martinez-Lopez, Joaquin...
HemaSphere.  7 (2023)  2 - p. e829 , 2023
Link: https://doi.org/10.1097/..
 
?
6

Real-World Health Care Services Utilization Associated With..:

Ocio, Enrique M. ; Montes-Gaisán, Carmen ; Bustamante, Gabriela...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  10 - p. e341-e347 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Randomized phase II study of weekly carfilzomib 70 mg/m2 an..:

Puertas, Borja ; González-Calle, Verónica ; Sureda, Anna...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
8

Feasibility of a Hospital-at-Home Program for Autologous He..:

González-Barrera, Soledad ; Martín-Sánchez, Guillermo ; Parra-Jordán, Juan José...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. 111.e1-111.e7 , 2023
Link: https://doi.org/10.1016/..
 
?
9

ANCHOR: melflufen plus dexamethasone and daratumumab or bor..:

Ocio, Enrique M. ; Efebera, Yvonne A. ; Hájek, Roman...
Haematologica.  109 (2023)  3 - p. 867-876 , 2023
Link: https://doi.org/10.3324/..
 
?
10

Clinical and Sociodemographic Characteristics of Patients W..:

Ocio, Enrique M. ; Montes-Gaisán, Carmen ; Bustamante, Gabriela...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  4 - p. e241-e249 , 2022
Link: https://doi.org/10.1016/..
 
?
11

DRUGGABLE MM THERAPEUTICS: PATHOGENETIC PATHWAYS:

Ocio, Enrique M
HemaSphere.  6 (2022)  - p. 1-1 , 2022
Link: https://doi.org/10.1097/..
 
?
12

Poster: MM-071 Subcutaneous (SC) Isatuximab (Isa) Administr..:

Quach, Hang ; Parmar, Gurdeep ; Ocio, Enrique M....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S179 , 2022
Link: https://doi.org/10.1016/..
 
?
13

MM-071 Subcutaneous (SC) Isatuximab (Isa) Administration by..:

Quach, Hang ; Parmar, Gurdeep ; Ocio, Enrique M....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S404-S405 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Recovery of polyclonal immunoglobulins during treatment in ..:

Dávila, Julio ; González‐Calle, Verónica ; Escalante, Fernando...
British Journal of Haematology.  198 (2022)  2 - p. 278-287 , 2022
Link: https://doi.org/10.1111/..
 
?
15

A simple score to predict early severe infections in patien..:

Encinas, Cristina ; Hernandez-Rivas, José-Ángel ; Oriol, Albert...
Blood Cancer Journal.  12 (2022)  4 - p. , 2022
Link: https://doi.org/10.1038/..
 
1-15